Brief: Echoiq Enters Commercial Licensing Agreement With Respiri
25/01/2024 01:07
Jan 25 (Reuters) - EchoIQ Ltd EIQ.AX :
* ENTERED INTO A COMMERCIAL LICENSING AGREEMENT WITH RESPIRI
* AGREEMENT TO APPLY CO'S AI-BACKED ECHOSOLVTM
CARDIOVASCULAR
DECISION SUPPORT TO RESPIRI'S REMOTE PATIENT MONITORING USER
BASE
Source text for Eikon: ID:nASX5rK1Y5
Further company coverage: EIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitasora Health
See all newsBrief: Vitasora Health Raises A$4 Million In Placement
Brief: Vitasora Health Seeks Trading Halt
Australia's Vitasora Health soars on extending deal with Evolent Care Partners
Brief: Vitasora Health Posts Quarterly Revenue Of A$1.12 MLN
Australia's Vitasora Health hits over 2-month low on discounted placement